FT reporting in the past hour that Gilead terminated its randomized clinical trials of the drug Remdesivir in China since the results did not warrant continuation. This was another one of the drugs touted by the President in his self-proclaimed role of “Good New Donald”. There are still other ongoing studies of this same drug in the U.S. so hopefully they might offer more positive outcomes.
There is a high likelihood that one of these drugs in clinical evaluation will show positive outcomes, but it may take weeks or months. However, promoting individual drugs on the basis of political connections, rumors or “whims” is reckless and dangerous.
Menu